Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexaria Bioscience (LEXX) Return on Assets (2017 - 2025)

Lexaria Bioscience's Return on Assets history spans 9 years, with the latest figure at 2.1% for Q4 2025.

  • For Q4 2025, Return on Assets fell 132.0% year-over-year to 2.1%; the TTM value through Nov 2025 reached 2.1%, down 132.0%, while the annual FY2025 figure was 1.82%, 86.0% down from the prior year.
  • Return on Assets for Q4 2025 was 2.1% at Lexaria Bioscience, up from 2.18% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.0% in Q3 2021 and bottomed at 67.69% in Q2 2023.
  • The 5-year median for Return on Assets is 1.15% (2025), against an average of 6.24%.
  • The largest annual shift saw Return on Assets crashed -6712bps in 2023 before it skyrocketed 5091bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.16% in 2021, then plummeted by -467bps to 0.92% in 2022, then crashed by -311bps to 3.78% in 2023, then soared by 79bps to 0.78% in 2024, then tumbled by -169bps to 2.1% in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Return on Assets are 2.1% (Q4 2025), 2.18% (Q3 2025), and 1.48% (Q2 2025).